TrialSeminars in arthritis and rheumatism2020

The MUC5B promoter variant does not predict progression of interstitial lung disease in systemic sclerosis.

Elizabeth R Volkmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.